Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players√Ę‚ā¨‚ĄĘ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Microcarriers Market Research Report Information By Product Type (Equipment {Bioreactors, Culture Vessels, Cell Counters, Filtration Systems, and Other Equipment}, Consumables {Media [Serum-Based Media, Serum-Free Media, and Other Media], Reagents, Microcarrier Beads {Cationic Microcarriers, Collagen-coated Microcarriers, Protein-coated Microcarriers, and Other Microcarrier Beads}), By Application (Vaccine Manufacturing, Cell Therapy, Biologics Manufacturing, and Other Applications), By End User (Pharmaceutical & Biotechnology Companies, Re


ID: MRFR/LS/5446-HCR | 90 Pages | Author: Kinjoll Dey| April 2024

Global Microcarriers Market Research (MRFR Insights)


The Microcarrier Market is anticipated to reach USD 1.57 Billion by 2032 at 5.6% CAGR during the forecast period 2023-2032. The market's growth is attributed to the high demand for cell-based vaccines & therapeutics, increasing incidence of various diseases & disorders like diabetes, cancer, rheumatoid arthritis, hemophilia, and others, huge investments for the development of innovative therapies, and consistent technological advancements in cell biology research. The  microcarriers market size is expected to reach approximately USD 1.18 Billion by 2027. Moreover, the rising demand for cell-based vaccines is the prominent driving factor for the market. Earlier vaccines were created in eggs and then harvested, which was a time and labor-intensive process.


COVID-19 Impact Analysis


There was a considerable decrease in patient visits during the pandemic due to the cancellation of medical procedures, especially elective procedures, to stop the spread of the COVID-19 pandemic. As per an Elsevier Public Health Emergency Collection report, more than 89% of the total lens utilizers were affected by the pandemic, and 72% reported less utilization than usual. Furthermore, according to the study by the College of Optometrists, 43% to 72% of wearers decreased contact lens utilization because of the reduced requirement for lenses due to the limited outdoor activities. Moreover, in 2020, Johnson and Johnson Vision Care, Inc. registered a decline of 11.7% in revenue.


Microcarriers Market Dynamics


The growth in the cell therapy industry and the huge demand for biopharmaceutical products are contributing to the growth of the microcarrier industry. As microcarriers are the matrices that help the growth of adherent cells, these small beads have found high utilization in stem cell therapy. The conceivable therapeutic actions from mesenchymal stem cells and pluripotent stem cells have enhanced the demand for stem cell therapy for treating infrequent diseases. As these stem cells are adherent, huge production of cell therapies needs an extensive amount of microcarrier consumables. Moreover, technological advances have permitted the development of vaccines in cell cultures resulting in a time-efficient and large production of vaccines, even offering better protection. As per CDC, the US FDA has approved Flucelvax Quadrivalent, a cell culture-based flu vaccine for adults 6 months and older. The growing incidence of infectious & chronic diseases, along with the current pandemic, is expected to drive the microcarrier's marketspace and result in strong growth during the forecasted period.


Market Drivers



  • Growing demand for cell-based vaccines


The enhancement in population, climate change, and increasing contact between humans and animals has increased the threat of new viruses. The growing incidence of infectious diseases and the increasing risk of pandemics are expected to drive vaccine demand worldwide. Cell culture is increasingly becoming a major part of vaccine production in the pharmaceutical industry. Vaccines were manufactured by increasing and harvesting viruses in chicken eggs, a time-consuming process. In this regard, cell-based vaccine production has become a far more efficient method owing to its shortened lead time and the capacity to produce vaccines in larger quantities according to demand.


Market Restraints:



  • The high price of cell biology research


Cell biology includes R&D on new therapies, including stem cell and gene therapies. The equipment, media, reagents, and other products related to research must be of the highest quality to deliver accurate results. Owing to the growing requirement to maintain high-quality standards (through high-grade products) and comply with guidelines set up by regulatory bodies, the cost of cell biology research has risen considerably. As a result, academic institutes and small-scale firms with limited budgets cannot afford to perform cell biology research. Since microcarriers discover applications in stem cell biology, this factor will likely hamper the market growth.


Market Opportunities:



  • Growing monoclonal antibody production


The demand for monoclonal antibodies is increasing ly due to the growing popularity of targeted treatment options for indications, including oncology and autoimmune & inflammatory disorders. As antibodies are administered in huge doses, the requirement for mAbs is equally high. Many current biologics in the pipeline target the indications, which are small-molecule-dominated and have a large patient pool. This represents that in the forecast period, the trend of biologics could enter several of the non-traditional biologic disease areas, which could benefit from the increased therapeutic efficacy.


Microcarriers Market Segmentation


Microcarriers Product Type Insights


The  microcarriers market segmentation, based on product type, is equipment {bioreactors, culture vessels, cell counters, filtration systems, and other equipment}, consumables {media [serum-based media, serum-free media, and other media], reagents, microcarrier beads {cationic microcarriers, collagen-coated microcarriers, protein-coated microcarriers, and other microcarrier beads}. The  microcarriers market growth was prominently high under the microcarrier beads category in 2021 due to increased cell biology research, increasing requirement for regenerative medicines and biopharmaceuticals, and the existence of several microcarrier beads that can be employed for different purposes attributed to the significant market growth.


Microcarriers Application Insights


The  microcarriers market segmentation, based on application, is vaccine manufacturing, cell therapy, biologics manufacturing, and other applications. In 2021, cell therapy accounted for the largest share of the  market due to the increased adoption of microcarriers for cell therapy. However, vaccine manufacturing is to register the highest growth rate during the forecast period due to the growing demand for vaccines for various viruses.


Microcarriers End User Insights


Based on end user, the  market is divided into pharmaceutical & biotechnology companies, research institutes, and contract research organizations. The pharmaceutical & biotechnology companies category dominated the market for microcarriers in 2021 due to the increasing incidence of cancer and growing cases of infectious diseases & genetic disorders, resulting in the growing demand for producing safe & effective medicines or treatments.


Global Microcarriers Market Share, by Region, 2021 (%)Microcarriers Market Share, by Region, 2021Microcarriers Market Overview, by Region Insights


By region, the  microcarriers market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the most extensive market share. Asia-Pacific will exhibit the highest CAGR during the forecast period.


North America


North America dominated the market share in 2021. The growing cases of chronic and infectious diseases, enhanced awareness of personalized medicines, improved healthcare infrastructure and reimbursement models, existence of key market players, and intensive R&D activities have fueled the region's growth. Moreover, regulatory assistance for biopharmaceuticals and regenerative medicines is also driving the market entry of new cell-based therapies. For instance, the US FDA predicts by 2025. It'll be approving approximately 10 to 20 cell and gene therapy products each year owing to the current clinical success speeds and the product pipeline.


Asia-Pacific


Asia-Pacific accounted for the second-largest market share in the  market in 2021. The government inducements for vaccine production and low operation & labor charges drive multiple regional research settings. The Asia Pacific region is also driven by the high domestic demand for biologics and growing economies and has the highest senior population. Furthermore, several local Asian and international firms are developing several of the globe's new bioprocessing structures in this region. For instance, in October 2021, Singapore noticed the enhancement of Lonza's facility for mammalian services. The CDMO has added this capacity to assist growing manufacturing & analytical needs.


Microcarriers Market Competitive Landscape


The market includes tier-1, tier-2, and local market players. The tier-1 and tier-2 market players have  reach with diverse product portfolios. Companies such as Thermo Fisher Scientific, Inc., Sartorius AG, Merck KGaA, Danaher Corporation, HiMedia Laboratories Pvt. Ltd., and Eppendorf SE dominate the  market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are concentrating on supporting research and development. Furthermore, they embrace strategic growth initiatives, such as development, joint ventures, product introduction, and partnerships, to strengthen their market position and capture an extensive customer base.


Prominent players in the  microcarriers market research include Corning Incorporated, VWR International LLC, Lonza Group Ltd, Merck KGaA, Bio-Rad Laboratories, Inc., and denovoMATRIX GmbH, among others.


Microcarriers Market Segmentation


Microcarriers Product Type Outlook



  • Equipment

    • Bioreactors

    • Culture Vessels

    • Cell Counters

    • Filtration Systems

    • Other Equipment



  • Consumables

    • Media

      • Serum-Based Media

      • Serum-Free Media

      • Other Media



    • Reagents

    • Microcarrier Beads

      • Cationic Microcarriers

      • Collagen-coated Microcarriers

      • Protein-coated Microcarriers

      • Other Microcarrier Beads






Microcarriers Application Outlook



  • Vaccine Manufacturing

  • Cell Therapy

  • Biologics Manufacturing

  • Other Applications


Microcarriers End User Outlook



  • Pharmaceutical & Biotechnology Companies

  • Research Institutes

  • Contract Research Organizations


Microcarriers Region Outlook



  • North America

    • US

    • Canada

    • Mexico



  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia and New Zealand

    • Rest of Asia-Pacific



  • Rest of the World

    • South America

    • Middle East

    • Africa




Objectives of the Study


The objectives of the study are summarized in 5 stages. They are as mentioned below:


Microcarriers Market Forecast & Size:


To identify and estimate the market size for the  microcarriers market report segmented by product type, application, and end-user by value (in US dollars). Also, to understand the consumption/ demand created by consumers in the  microcarriers market forecast between 2022 and 2030


Market Landscape and Trends:


To identify and infer the drivers, opportunities, restraints, and challenges in the  microcarriers market growth


Market Influencing Factors:


To find out the factors which are impacting the  microcarriers market size among consumers


Impact of COVID-19:


To identify and understand the several factors involved in the market affected by the pandemic


Company Profiling:


To provide a detailed insight into the key companies operating in the market. The profiling will include the company's financial health in the past 2-3 years with segmental and regional revenue breakup, product offering, SWOT analysis, recent developments, and key strategies.


Intended Audience



  • Microcarriers producers

  • Raw material suppliers

  • Retailers, wholesalers, and distributors

  • Governments, associations, and industrial bodies

Report Attribute/Metric Details
  Market Size   USD 1.57 Billion
  CAGR   5.6% CAGR
  Base Year   2022
  Forecast Period   2023-2032
  Historical Data   2021
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Application, and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
  Key Vendors Corning Incorporated, VWR International LLC, Lonza Group Ltd, Merck KGaA, Bio-Rad Laboratories, Inc., and denovoMATRIX GmbH
  Key Market Opportunities   Rising monoclonal antibody production
  Key Market Drivers   Rising demand for cell-based vaccines


Frequently Asked Questions (FAQ) :

The  microcarriers market forecast period is 2023-2032

The market is expected to register a CAGR of ~5.6% over the next 10 years, according to  microcarriers market research.

Asia-Pacific is expected to register the highest CAGR during 2023 - 2032

North America held the largest share in 2021

The market size is expected to be USD 1.57 Billion by 2032.

Sartorius AG, Merck KGaA, Danaher Corporation, Thermo Fisher Scientific, Inc., HiMedia Laboratories Pvt. Ltd., and Eppendorf SE are the major companies operating ly market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization